<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Manufacturing Obstacles in Life&amp;#160;Sciences</title><link>/community-hubs/deltav-community-connect/b/ops-weblog/posts/manufacturing-obstacles-in-life-160-sciences</link><description>In an article, From Industrial To Investment Strategies In The Life Science Sector, Life Science Leader magazine has a great recap of some of the issues pharmaceutical and biotech manufacturers face in their manufacturing processes. The article highlights</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>